Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price was up 47.4% on Friday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares were traded during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm’s 50 day moving average is C$0.08 and its 200-day moving average is C$0.06. The stock has a market capitalization of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Basic Materials Stocks Investing
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What is the Nikkei 225 index?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
